Seattle, Washington
United States
390
2021-05-13
361
2023-01-03
These are the the leading inventors for applications assigned to ZYMOGENETICS, INC.:
ZYMOGENETICS, INC. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#2 | 2020-08-20 ā Patent 11,542,327 granted on 2023-01-03Methods of treating pruritic disease with IL-31 monoclonal antibodies
#3 | 2020-07-30 ā Patent 11,312,779 granted on 2022-04-26Methods of treating prurigo nodularis using anti-IL-31RA antibody compositions
#4 | 2017-11-02 ā Patent 9,982,044 granted on 2018-05-29Method of treating pruritus with IL-31 monoclonal antibody formulations
#5 | 2017-08-17 ā Patent 10,023,656 granted on 2018-07-17Methods of treating inflammation using IL-17A and IL-17F cross-reactive monoclonal antibodies
#6 | 2017-05-11 ā Patent 9,822,177 granted on 2017-11-21Method of reducing pruritus using IL-31 monoclonal antibodies
#7 | 2016-12-29 ā Patent 9,994,634 granted on 2018-06-12Use of an IL-17/IL-23 bispecific antibody for treating inflammation
#8 | 2016-10-27 ā Patent 9,738,715 granted on 2017-08-22IL-31 monoclonal antibody formulations
#9 | 2016-10-27 ā Patent 10,000,563 granted on 2018-06-19Monoclonal antibodies that bind both IL-17A and IL-17F
#10 | 2016-08-04 ā Patent 9,631,022 granted on 2017-04-25Method treating neuronal tissue inflammation using an IL-31RA monoclonal antibody
#11 | 2016-08-04 ā Patent 9,631,021 granted on 2017-04-25Use of an IL-31 monoclonal antibody for antagonizing signal transduction in spinal cord cells
#12 | 2016-03-03 ā Patent 9,738,700 granted on 2017-08-22ZCYTOR17 heterodimeric cytokine receptor
#13 | 2016-02-25 ā Patent 9,663,572 granted on 2017-05-30Antibodies that bind both IL-17A and IL-17F
#14 | 2016-02-25COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#15 | 2015-07-16 ā Patent 9,464,134 granted on 2016-10-11Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19
#16 | 2015-07-02 ā Patent 9,624,296 granted on 2017-04-18Polynucleotides encoding IL-31 monoclonal antibodies
#17 | 2015-01-08 ā Patent 9,605,062 granted on 2017-03-28Polynucleotides encoding ZCYTOR17 ligand antibodies
#18 | 2014-11-06 ā Patent 9,346,878 granted on 2016-05-24Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins
#19 | 2014-09-18METHOD FOR TREATING INFLAMMATION
#20 | 2014-08-07 ā Patent 9,725,506 granted on 2017-08-08Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
#21 | 2014-06-26 ā Patent 9,499,598 granted on 2016-11-22Mutants of IL-29
#22 | 2014-05-22 ā Patent 9,212,213 granted on 2015-12-15ZCYTOR17 heterodimeric cytokine receptor
#23 | 2014-04-17 ā Patent 9,663,566 granted on 2017-05-30Soluble hybrid Fcγ receptors and related methods
#24 | 2014-03-20 ā Patent 9,156,909 granted on 2015-10-13Polynucleotides encoding IL-31 monoclonal antibodies
#25 | 2014-01-02METHOD FOR TREATING CERVICAL CANCER
#26 | 2013-12-12 ā Patent 9,146,242 granted on 2015-09-29Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods
#27 | 2013-12-12 ā Patent 8,900,578 granted on 2014-12-02Anti-IL-TIF antibodies
#28 | 2013-11-28ANTI-IL-22RA ANTIBODIES
#29 | 2013-11-21 ā Patent 8,992,922 granted on 2015-03-31Antagonists of IL-17A, IL-17F, and IL-23P19
#30 | 2013-11-21 ā Patent 8,815,238 granted on 2014-08-26Methods for Preparing TACI-immunoglobulin fusion proteins
#31 | 2013-11-14 ā Patent 8,728,469 granted on 2014-05-20Method of treating rheumatoid arthritis using anti-IL-20 antibodies
#32 | 2013-11-07 ā Patent 8,685,669 granted on 2014-04-01Nucleic acid molecules encoding humanized antibody molecules specific for IL-31
#33 | 2013-10-31 ā Patent 8,871,467 granted on 2014-10-28Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#34 | 2013-08-15 ā Patent 8,834,879 granted on 2014-09-16Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis
#35 | 2013-08-08 ā Patent 8,926,957 granted on 2015-01-06Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
#36 | 2013-08-01 ā Patent 8,685,395 granted on 2014-04-01Methods of antagonizing signal transduction in dorsal root ganglion cells
#37 | 2013-07-11 ā Patent 8,637,015 granted on 2014-01-28Methods of antagonizing signal transduction in dorsal root ganglion cells
#38 | 2013-06-20 ā Patent 8,778,344 granted on 2014-07-15Method of treating atopic dermatitis with antibody to zcytor17 ligand
#39 | 2013-06-06 ā Patent 8,759,027 granted on 2014-06-24Production and purification of IL-29
#40 | 2013-06-06 ā Patent 8,647,866 granted on 2014-02-11ZCYTOR17 heterodimeric cytokine receptor polynucleotides
#41 | 2013-06-06ANTIBODY TO HUMAN ZCYTO-10 POLYPEPTIDE
#42 | 2013-04-11 ā Patent 8,734,776 granted on 2014-05-27Mutants of IL-29
#43 | 2013-02-14 ā Patent 8,648,182 granted on 2014-02-11Polynucleotides encoding antibodies to cytokine receptor zcytor17
#44 | 2013-01-31METHODS OF TREATING IL-TIF ASSOCIATED INFLAMMATORY OR IMMUNE DISEASES USING ANTIBODIES AGAINST SOLUBLE ZCYTOR 11 CYTOKINE RECEPTORS
#45 | 2013-01-24 ā Patent 8,431,129 granted on 2013-04-30Method of treating fibroproliferative disorders of the heart and lung
#46 | 2013-01-24 ā Patent 8,816,053 granted on 2014-08-26Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#47 | 2012-12-27 ā Patent 8,481,288 granted on 2013-07-09Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#48 | 2012-11-22 ā Patent 8,496,936 granted on 2013-07-30Antagonists of IL-17A, IL-17F, and IL-23P19
#49 | 2012-11-15METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS
#50 | 2012-11-08 ā Patent 9,388,241 granted on 2016-07-12Anti-human IL-21 antibodies
#51 | 2012-09-06 ā Patent 8,361,470 granted on 2013-01-29Methods of treatment using anti-human IL-21 monoclonal antibodies
#52 | 2012-08-16 ā Patent 8,383,775 granted on 2013-02-26Cytokine zalpha11 ligand
#53 | 2012-08-16 ā Patent 8,372,602 granted on 2013-02-12Methods for producing cytokine receptor ZALPHA11
#54 | 2012-08-16ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
#55 | 2012-08-16 ā Patent 8,409,571 granted on 2013-04-02Methods of antagonizing signal transduction in spinal cord cells
#56 | 2012-07-26 ā Patent 8,378,079 granted on 2013-02-19Antibody to human zcyto-10 polypeptide
#57 | 2012-07-26 ā Patent 8,524,227 granted on 2013-09-03Anti-IL-TIF antibodies
#58 | 2012-07-12 ā Patent 8,226,948 granted on 2012-07-24Anti-human IL-21 monoclonal antibodies
#59 | 2012-07-05 ā Patent 8,349,590 granted on 2013-01-08FGF homologs compositions and uses thereof
#60 | 2012-06-21 ā Patent 8,536,309 granted on 2013-09-17Methods of producing anti-IL-22RA antibodies
#61 | 2012-06-21 ā Patent 8,475,791 granted on 2013-07-02Anti-IL-TIF antibodies and methods of use
#62 | 2012-06-07 ā Patent 8,231,866 granted on 2012-07-31Cytokine protein family
#63 | 2012-05-03 ā Patent 8,377,438 granted on 2013-02-19Methods of antagonizing signal transduction in spinal cord cells
#64 | 2012-04-12 ā Patent 8,562,984 granted on 2013-10-22Methods of treatment using anti-IL-20 antibodies
#65 | 2012-04-05 ā Patent 8,298,524 granted on 2012-10-30Methods of using IL-31 to treat chronic obstructive pulmonary disease (COPD)
#66 | 2012-04-05 ā Patent 8,242,072 granted on 2012-08-14Methods of treating inflammation using soluble IL-17RA/RC fusion proteins
#67 | 2012-01-26GROWTH FACTOR HOMOLOG ZVEGF4
#68 | 2012-01-26 ā Patent 8,318,147 granted on 2012-11-27Use of IL-29 for treating a dengue virus infection
#69 | 2012-01-19 ā Patent 8,211,670 granted on 2012-07-03Production and purification of IL-29
#70 | 2012-01-05 ā Patent 8,343,476 granted on 2013-01-01Method of using IL-29 cystehne mutant to treat hepatitis C and hepatitis B
#71 | 2011-12-08 ā Patent 8,283,448 granted on 2012-10-09Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#72 | 2011-12-01 ā Patent 8,568,723 granted on 2013-10-29Method of reducing pruritis using IL-31 monoclonal antibodies
#73 | 2011-11-24 ā Patent 8,309,692 granted on 2012-11-13Antibodies to cytokine receptor ZCYTOR17
#74 | 2011-09-22 ā Patent 8,524,232 granted on 2013-09-03Methods of treatment using taci-immunoglobulin fusion proteins
#75 | 2011-09-08 ā Patent 8,658,766 granted on 2014-02-25Soluble hybrid Fcγ receptors and related methods
#76 | 2011-09-01 ā Patent 8,388,964 granted on 2013-03-05Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
#77 | 2011-08-11 ā Patent 8,124,378 granted on 2012-02-28Murine zcytor17 ligand polynucleotides
#78 | 2011-08-11 ā Patent 8,124,065 granted on 2012-02-28Cytokine Protein Family
#79 | 2011-07-28 ā Patent 8,110,372 granted on 2012-02-07Methods for detecting modulators of cytokine receptor zalpha11
#80 | 2011-07-21 ā Patent 8,105,591 granted on 2012-01-31Methods of antagonizing signal transduction in dorsal root ganglion cells
#81 | 2011-07-21 ā Patent 8,268,773 granted on 2012-09-18Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist
#82 | 2011-07-21 ā Patent 8,105,590 granted on 2012-01-31Methods of treating inflammation in neuronal tissue
#83 | 2011-07-21 ā Patent 8,313,739 granted on 2012-11-20Use of truncated cysteine IL28 and IL29 Mutants to treat cancers and autoimmune disorders
#84 | 2011-07-14 ā Patent 8,222,374 granted on 2012-07-17IL-21 antagonists
#85 | 2011-07-07 ā Patent 9,597,062 granted on 2017-03-21Medical devices for delivering fluids during surgery and methods for their use
#86 | 2011-06-30 ā Patent 8,333,968 granted on 2012-12-18Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19
#87 | 2011-06-23 ā Patent 8,759,066 granted on 2014-06-24Thrombin activator compositions and methods of making and using the same
#88 | 2011-06-23 ā Patent 8,124,356 granted on 2012-02-28Methods of purifying zsig33
#89 | 2011-06-23 ā Patent 8,133,487 granted on 2012-03-13Soluble heterodimeric cytokine receptor
#90 | 2011-06-02 ā Patent 8,241,629 granted on 2012-08-14Anti-human IL-21 monoclonal antibodies
#91 | 2011-05-26 ā Patent 9,629,798 granted on 2017-04-25Hemostatic microspheres
#92 | 2011-05-19 ā Patent 9,139,651 granted on 2015-09-22Methods of treatment using IL-31RA
#93 | 2011-05-12SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING
#94 | 2011-05-12SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING
#95 | 2011-04-07 ā Patent 8,124,739 granted on 2012-02-28Antibody to human Zcyto10 polypeptide
#96 | 2011-04-07 ā Patent 8,287,866 granted on 2012-10-16Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
#97 | 2011-04-07 ā Patent 8,790,643 granted on 2014-07-29Methods for treating disease using an anti-IL-21 receptor antibody
#98 | 2011-03-10 ā Patent 8,227,579 granted on 2012-07-24IL-23 antagonists
#99 | 2011-03-03 ā Patent 7,919,595 granted on 2011-04-05Antibodies to interferon-like protein Zcyto21(IL29)
#100 | 2011-03-03METHOD OF TREATING HEPATOCELLULAR CARCINOMA
Also check out ZymoGenetics, Inc.'s (Seattle, United States) applicant profile with 7 patent applications submitted.
5860 ā